» Articles » PMID: 35019212

Quality Assurance for On-table Adaptive Magnetic Resonance Guided Radiation Therapy: A Software Tool to Complement Secondary Dose Calculation and Failure Modes Discovered in Clinical Routine

Overview
Date 2022 Jan 12
PMID 35019212
Authors
Affiliations
Soon will be listed here.
Abstract

Online adaption of treatment plans on a magnetic resonance (MR)-Linac enables the daily creation of new (adapted) treatment plans using current anatomical information of the patient as seen on MR images. Plan quality assurance (QA) relies on a secondary dose calculation (SDC) that is required because a pretreatment measurement is impossible during the adaptive workflow. However, failure mode and effect analysis of the adaptive planning process shows a large number of error sources, and not all of them are covered by SDC. As the complex multidisciplinary adaption process takes place under time pressure, additional software solutions for pretreatment per-fraction QA need to be used. It is essential to double-check SDC input to ensure a safe treatment delivery. Here, we present an automated treatment plan check tool for adaptive radiotherapy (APART) at a 0.35 T MR-Linac. It is designed to complement the manufacturer-provided adaptive QA tool comprising SDC. Checks performed by APART include contour analysis, electron density map examinations, and fluence modulation complexity controls. For nine of 362 adapted fractions (2.5%), irregularities regarding missing slices in target volumes and organs at risks as well as in margin expansion of target volumes have been found. This demonstrates that mistakes occur and can be detected by additional QA measures, especially contour analysis. Therefore, it is recommended to implement further QA tools additional to what the manufacturer provides to facilitate an informed decision about the quality of the treatment plan.

Citing Articles

Mitigating Risks in Cone Beam Computed Tomography Guided Online Adaptive Radiation Therapy: A Preventative Reference Planning Review Approach.

Rahman M, Iqbal Z, Parsons D, Salazar D, Visak J, Zhong X Adv Radiat Oncol. 2024; 9(11):101614.

PMID: 39399639 PMC: 11470165. DOI: 10.1016/j.adro.2024.101614.


Enhancing patient safety in radiotherapy: Implementation of a customized electronic checklist for radiation therapists.

Lastrucci A, Esposito M, Serventi E, Marrazzo L, Francolini G, Simontacchi G Tech Innov Patient Support Radiat Oncol. 2024; 31:100255.

PMID: 38882236 PMC: 11176772. DOI: 10.1016/j.tipsro.2024.100255.


Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in Spain.

Gonsalves D, Ocanto A, Meilan E, Gomez A, Dominguez J, Torres L Cancers (Basel). 2024; 16(9).

PMID: 38730637 PMC: 11083553. DOI: 10.3390/cancers16091685.


Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.

Fink C, Buchele C, Baumann L, Liermann J, Hoegen P, Ristau J Front Oncol. 2024; 14:1308406.

PMID: 38425342 PMC: 10902126. DOI: 10.3389/fonc.2024.1308406.


Leaf-individual calibration for a double stack multileaf collimator in photon radiotherapy.

Rippke C, Renkamp C, Attieh C, Schluter F, Buchele C, Debus J Phys Imaging Radiat Oncol. 2023; 27:100477.

PMID: 37635846 PMC: 10457557. DOI: 10.1016/j.phro.2023.100477.


References
1.
Nachbar M, Monnich D, Dohm O, Friedlein M, Zips D, Thorwarth D . Automatic 3D Monte-Carlo-based secondary dose calculation for online verification of 1.5 T magnetic resonance imaging guided radiotherapy. Phys Imaging Radiat Oncol. 2021; 19:6-12. PMC: 8295847. DOI: 10.1016/j.phro.2021.05.002. View

2.
McNiven A, Sharpe M, Purdie T . A new metric for assessing IMRT modulation complexity and plan deliverability. Med Phys. 2010; 37(2):505-15. DOI: 10.1118/1.3276775. View

3.
Ford E, Gaudette R, Myers L, Vanderver B, Engineer L, Zellars R . Evaluation of safety in a radiation oncology setting using failure mode and effects analysis. Int J Radiat Oncol Biol Phys. 2009; 74(3):852-8. PMC: 3655406. DOI: 10.1016/j.ijrobp.2008.10.038. View

4.
Tetar S, Bruynzeel A, Lagerwaard F, Slotman B, Bohoudi O, Palacios M . Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer. Phys Imaging Radiat Oncol. 2021; 9:69-76. PMC: 7807673. DOI: 10.1016/j.phro.2019.02.002. View

5.
Garcia Schuler H, Pavic M, Mayinger M, Weitkamp N, Chamberlain M, Reiner C . Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience. Radiat Oncol. 2021; 16(1):217. PMC: 8591958. DOI: 10.1186/s13014-021-01945-9. View